Literature DB >> 29102343

Crossing techniques and devices in femoropopliteal chronic total occlusion intervention.

Hemal Bhatt1, Sean Janzer1, Jon C George2.   

Abstract

Chronic total occlusions (CTO) are common in patients with symptomatic peripheral arterial disease. Endovascular CTO intervention remains a challenging endeavor for interventionalists, but is being increasingly considered as a plausible alternative to surgical revascularization, even for complex CTO lesions. We review common endovascular techniques using antegrade, retrograde and transcollateral approaches in femoropopliteal CTO intervention. In addition, we review the current literature on the utility, efficacy, and safety of novel crossing and re-entry devices in femoropopliteal CTO interventions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic total occlusion; Crossing devices; Peripheral arterial disease; Re-entry devices

Mesh:

Year:  2017        PMID: 29102343     DOI: 10.1016/j.carrev.2017.06.002

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  4 in total

Review 1.  Endovascular Materials and Their Behavior in Peripheral Vascular Surgery.

Authors:  Daniela Mazzaccaro; Matteo Giannetta; Paolo Righini; Alfredo Modafferi; Giovanni Malacrida; Giovanni Nano
Journal:  Front Surg       Date:  2022-05-04

2.  Optical coherence tomography and plaque morphology for revascularization of the superficial femoral artery.

Authors:  Jacob W Hartwig; Drew J Braet; Jamie B Smith; Jonathan Bath; Todd R Vogel
Journal:  Quant Imaging Med Surg       Date:  2021-01

3.  Five-year outcomes after revascularization of superficial femoral artery occlusion using Ocelot catheter.

Authors:  Przemysław Nowakowski; Piotr Buszman; Adam Janas; Stefan Kiesz; Pawel Buszman
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-12-08       Impact factor: 1.426

4.  Research in Vascular Medicine: Where We Are and Where We Are Going.

Authors:  Salah D Qanadli
Journal:  Front Cardiovasc Med       Date:  2020-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.